- Home
- AMLX vs WT Comparison
AMLX vs WT Comparison
Compare AMLX & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMLX | WT |
|---|---|---|
| Founded | 2014 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | AMLX | WT |
|---|---|---|
| Price | $17.61 | $18.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $20.11 | $17.33 |
| AVG Volume (30 Days) | 1.2M | ★ 3.3M |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.69% |
| EPS Growth | 65.46 | ★ 127.27 |
| EPS | N/A | ★ 0.75 |
| Revenue | $380,786,000.00 | ★ $493,753,000.00 |
| Revenue This Year | N/A | $35.04 |
| Revenue Next Year | N/A | $8.68 |
| P/E Ratio | ★ N/A | $23.27 |
| Revenue Growth | ★ 1612.94 | 15.43 |
| 52 Week Low | $4.41 | $8.18 |
| 52 Week High | $18.61 | $17.87 |
Technical Indicators
Market Signals| Indicator | AMLX | WT |
|---|---|---|
| Relative Strength Index (RSI) | 64.35 | 70.09 |
| Support Level | $13.19 | $13.07 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.91 | 0.74 |
| MACD | 0.26 | 0.37 |
| Stochastic Oscillator | 83.26 | 96.85 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.